News

Filter

Thought leaders indicate Benlysta has advantages over market leader CellCept for Lupus

26-04-2012

Surveyed US rheumatologists and managed care organization (MCO) pharmacy directors agree that reducing…

Anti-Arthritics/RheumaticsBenlystaCellCeptEli LillyforigerimodGlaxoSmithKlineHuman Genome SciencesImmuPharmaMarkets & MarketingNorth AmericaPharmaceuticalRare diseasesRocheSymBio Pharmaceuticalstabalumab

Important decision for the biotech industry from UK Supreme Court

03-11-2011

The UK’s Supreme Court yesterday gave guidance on the patentability of gene sequence inventions,…

BenlystaBiotechnologyEli LillyEuropeGlaxoSmithKlineHuman Genome SciencesLegalPatentsPharmaceutical

Back to top